Combination therapy with triamcinolone acetonide and bevacizumab for the treatment of severe radiation maculopathy in patients with posterior uveal melanoma

PURPOSE: To evaluate the role of intravitreal triamcinolone acetonide in patients who developed severe, visually compromising radiation maculopathy or progressed despite anti-angiogenic treatments. METHODS: An Institutional Review Board approved, consecutive, retrospective study from 2006 to 2009 of...

Descripción completa

Detalles Bibliográficos
Autores principales: Shah, Nisha V, Houston, Samuel K, Markoe, Arnold, Murray, Timothy G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3788818/
https://www.ncbi.nlm.nih.gov/pubmed/24092966
http://dx.doi.org/10.2147/OPTH.S47684

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3788818/
https://www.ncbi.nlm.nih.gov/pubmed/24092966
http://dx.doi.org/10.2147/OPTH.S47684

Ejemplares similares